Metformin-induced encephalopathy without lactic acidosis in a patient with contraindication for metformin.
A 51-year-old Korean man with end-stage renal disease and who was on intermittent hemodialysis was admitted with progressive dysarthria, gait disturbance, and myoclonus. The liver function tests and the electrolyte and arterial gas analyses were normal. The Magnetic resonance imaging scan showed a diffuse symmetric high signal intensity in the basal ganglia on the T2-weighted image. After a thorough history taking, we knew that he had been treated with metformin for 3 months at other hospital without our hospitals staff's knowledge. After stopping the metformin, the patient's neurologic signs and symptoms disappeared and the Magnetic resonance imaging findings after 20 days were markedly improved.
Jung
Eun Young
EY
Department of Internal Medicine, Good Sam-Jung Hospital, Ulsan, Korea.
Cho
Hyun Seop
HS
Seo
Jong Woo
JW
Kim
Dong Wook
DW
Kim
Hyun-Jung
HJ
Chang
Se-Ho
SH
Park
Dong Jun
DJ
D000140:Acidosis, Lactic; D001927:Brain Diseases / Q000139:chemically induced* / Q000473:pathology; D000075202:Contraindications; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000628:therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008687:Metformin / Q000009:adverse effects*; D008875:Middle Aged; D006435:Renal Dialysis
D007004:Hypoglycemic Agents; D008687:Metformin